
|Articles|June 1, 2004
Biotech company previews cutting edge dermatologic research
San Francisco - When Ivor Caro, M.D., now medical director of dermatology at Genentech Inc., joined the South San Francisco-based biotechnology company last year, he saw great potential for dermatology research.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














